Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Strawberries: What to Eat to Fight Inflammatory Bowel Disease
• Opioid Prescribing Guidelines: Tailoring to the Surgical Procedure
• Keeping Younger Pitchers in the Game
• Benefits of Palliative Care for Patients With Diagnoses of Advanced Illness
• A Promising Alternative for Pain Management?
• Changing Public Perception: Opioid Abuse Response
• Opioids and Wisdom Tooth Extraction: More Risk Than Benefit
• CRPS—Treat What you Can and Get the Patient Moving!
• Reducing Rheumatoid Arthritis Symptoms: Can Vitamin D Help?
• Opioids Before Surgery Predicts Opioids After Surgery